185 related articles for article (PubMed ID: 24476504)
21. Recombinant luteinizing hormone as a survival and differentiation factor increases oocyte maturation in recombinant follicle stimulating hormone-supplemented mouse preantral follicle culture.
Cortvrindt R; Hu Y; Smitz J
Hum Reprod; 1998 May; 13(5):1292-302. PubMed ID: 9647562
[TBL] [Abstract][Full Text] [Related]
22. A cohort study of both human menopausal gonadotropin (HMG) and recombinant luteinizing hormone addition at early follicular stage in in vitro fertilization outcome: A STROBE-compliant study.
Xia X; Shi Y; Geng L; Liu D; Hou Z; Lin H; Li R; Wang H; Tao L; Meng F; Da J; Chen Y; Qiao J; Qian W; Li H
Medicine (Baltimore); 2019 May; 98(19):e15512. PubMed ID: 31083194
[TBL] [Abstract][Full Text] [Related]
23. [Ovarian stimulation with gonadotropins: comparison between recombinant FSH plus menotropins versus recombinant FSH + LH].
Santibáñez Morales A; Colín Licea EO; Durán Boullosa E; Sánchez Serrano P; Pashkova O
Ginecol Obstet Mex; 2014 May; 82(5):307-13. PubMed ID: 24937946
[TBL] [Abstract][Full Text] [Related]
24. LH improves early follicular recruitment in women over 38 years old.
Gómez-Palomares JL; Acevedo-Martín B; Andrés L; Ricciarelli E; Hernández ER
Reprod Biomed Online; 2005 Oct; 11(4):409-14. PubMed ID: 16274596
[TBL] [Abstract][Full Text] [Related]
25. Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients.
Martínez F; Clua E; Parera N; Rodríguez I; Boada M; Coroleu B
Gynecol Endocrinol; 2008 Apr; 24(4):188-93. PubMed ID: 18382904
[TBL] [Abstract][Full Text] [Related]
26. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
27. Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study.
Cruz M; Requena A; Agudo D; García-Velasco JA
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():124-133. PubMed ID: 28622634
[TBL] [Abstract][Full Text] [Related]
28. Recombinant gonadotropins.
Lathi RB; Milki AA
Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
[TBL] [Abstract][Full Text] [Related]
29. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
30. Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism.
Huseyin K; Berk B; Tolga K; Eser O; Ali G; Murat A
J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):833-838. PubMed ID: 30930300
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Andersen AN; Devroey P; Arce JC
Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
[TBL] [Abstract][Full Text] [Related]
32. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
33. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
Giles J; Alama P; Gamiz P; Vidal C; Badia P; Pellicer A; Bosch E
Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
[TBL] [Abstract][Full Text] [Related]
34. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
[TBL] [Abstract][Full Text] [Related]
36. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
Caserta D; Lisi F; Marci R; Ciardo F; Fazi A; Lisi R; Moscarini M
Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759
[TBL] [Abstract][Full Text] [Related]
37. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study.
Younis JS; Izhaki I; Ben-Ami M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):99-106. PubMed ID: 26304041
[TBL] [Abstract][Full Text] [Related]
38. The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age.
Younis JS; Izhaki I; Ben-Ami M
J Endocrinol Invest; 2017 Aug; 40(8):831-839. PubMed ID: 28290093
[TBL] [Abstract][Full Text] [Related]
39. Efficacy assessment of highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotropin during pituitary suppression in patients undergoing GIFT for unexplained infertility.
Campo S; Garcea N
Gynecol Endocrinol; 1998 Jun; 12(3):161-6. PubMed ID: 9675561
[TBL] [Abstract][Full Text] [Related]
40. The impact of adding hp-hMG in r-FSH started GnRH antagonist cycles on ART outcome.
Kan O; Simsir C; Atabekoglu CS; Sonmezer M
Gynecol Endocrinol; 2019 Oct; 35(10):869-872. PubMed ID: 30973022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
